Browsing by Author Garon, Edward

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 4 of 4
Issue DateTitleAuthor(s)Citation
2017Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: A phase 1 trialHui, Rina; Ahn, Myung-Ju; Eder, Joseph; et al, Various; Gandhi, L; Garon, Edward; Goldman, J W; Hellmann, M D; Horn, L; Leighl, Natasha; Patnaik, Amita; Western Clinical School: Medicine (Westmead)Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: A phase 1 trial, Annals of Oncology, vol.28, 4, 2017,pp 874-881
2015Pembrolizumab for the Treatment of Non-Small-Cell Lung CancerHui, Rina; Aggarwal, Charu; Balmanoukian, Ani; Carcereny, Enric; Eder, Joseph; et al, Various; Garon, Edward; Gubens, Matthew; Horn, Leora; Leighl, Natasha; Patnaik, Amita; Rizvi, Naiyer; Western Clinical School: Medicine (Westmead)Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer, The New England Journal of Medicine, vol.372, 71, 2015,pp 2018-2028
2018Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung CancerBoyer, Michael; Hui, Rina; Bischoff, Helge; Cheng, Susanna; Clingan, Philip R.; De Angelis, Flavia; Domine, Manuel; Esteban, Emilio; et al, Various; Felip, E; Gadgeel, Shirish; Gandhi, Leena; Garon, Edward; Grossi, Francesco; Hochmair, Maximilian; Jennens, Ross; Peled, Nir; Powell, Steen; Reck, M; Rodriguez-Abreu, Delvys; Rubio-Viqueira, Belen; Central Clinical School: Medicine; Westmead Clinical School: MedicinePembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer, New England Journal of Medicine, vol.378, 22, 2018,pp 2078-2092
2016Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancerHui, Rina; Arkenau, Hendrik-Tobias; Cappuzzo, F; Chatterjee, M; Dong, D; et al, .; Felip, E; Garon, Edward; Gubens, Matthew; Hellmann, M D; Horn, Leora; Lena, H; Li, C; Mayawala, K; Turner, D C; Western Clinical School: Medicine (Westmead)Systematic evaluation of pembrolizumab dosing in patients with advanced non-small-cell lung cancer, Annals of Oncology, vol.27, 7, 2016,pp 1291-1298